Abstract

Dilated cardiomyopathy (DCM) is a fatal heart disease characterized by left ventricular dilatation and cardiac dysfunction. Recent genetic studies on DCM have identified causative mutations in over 60 genes, including RBM20, which encodes a regulator of heart-specific splicing. DCM patients with RBM20 mutations have been reported to present with more severe cardiac phenotypes, including impaired cardiac function, atrial fibrillation (AF), and ventricular arrhythmias leading to sudden cardiac death, compared to those with mutations in the other genes. An RSRSP stretch of RBM20, a hotspot of missense mutations found in patients with idiopathic DCM, functions as a crucial part of its nuclear localization signals. However, the relationship between mutations in the RSRSP stretch and cardiac phenotypes has never been assessed in an animal model. Here, we show that Rbm20 mutant mice harboring a missense mutation S637A in the RSRSP stretch, mimicking that in a DCM patient, demonstrated severe cardiac dysfunction and spontaneous AF and ventricular arrhythmias mimicking the clinical state in patients. In contrast, Rbm20 mutant mice with frame-shifting deletion demonstrated less severe phenotypes, although loss of RBM20-dependent alternative splicing was indistinguishable. RBM20S637A protein cannot be localized to the nuclear speckles, but accumulated in cytoplasmic, perinuclear granule-like structures in cardiomyocytes, which might contribute to the more severe cardiac phenotypes.

Details

Title
A missense mutation in the RSRSP stretch of Rbm20 causes dilated cardiomyopathy and atrial fibrillation in mice
Author
Ihara Kensuke 1 ; Sasano Tetsuo 2 ; Hiraoka Yuichi 3 ; Togo-Ohno, Marina 4 ; Soejima Yurie 5 ; Sawabe Motoji 5 ; Tsuchiya Megumi 6 ; Ogawa Hidesato 6 ; Furukawa Tetsushi 7 ; Kuroyanagi Hidehito 4 

 Tokyo Medical and Dental University (TMDU), Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130); Tokyo Medical and Dental University (TMDU), Department of Cardiovascular Medicine, Tokyo, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130) 
 Tokyo Medical and Dental University (TMDU), Department of Cardiovascular Medicine, Tokyo, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130) 
 Tokyo Medical and Dental University (TMDU), Laboratory of Molecular Neuroscience, Medical Research Institute, Tokyo, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130) 
 Tokyo Medical and Dental University (TMDU), Laboratory of Gene Expression, Medical Research Institute, Tokyo, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130) 
 Tokyo Medical and Dental University (TMDU), Department of Molecular Pathology, Graduate School of Medical and Dental Sciences, Tokyo, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130) 
 Osaka University, Graduate School of Frontier Biosciences, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 Tokyo Medical and Dental University (TMDU), Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471527731
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.